BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Business

  VolitionRx Announces Third Quarter 2017 Financial Results and Business Update

  Volition management will host a conference call tomorrow, November 10, at 8:30 a.m. U.S. Eastern Time to discuss these results. Conference call details may be found below.

  November 9, 2017

   · 

  9 min read
• Business

  IntelGenx Reports Third Quarter 2017 Financial Results

  Total revenues for the three-month period ended September 30, 2017 amounted to $1.3 million, compared to $1.8 million for the three-month period ended September 30, 2016.

  November 9, 2017

   · 

  5 min read
• Business

  Athenex Announces Third Quarter 2017 Results

  Revenue for the three months ended September 30, 2017 was $14.0 million, an increase of $8.4 million, or 149%, as compared to $5.6 million for the three months ended September 30, 2016.

  November 9, 2017

   · 

  13 min read
• Cypralis to Present Pre-Clinical Data on Novel Cyclophilin D Inhibitor CC-1233 for Acute Pancreatitis at the American Pancreatic Association Meeting

  Cypralis, in collaboration with the University of Liverpool, will present in-vitro and in-vivo data obtained using novel cyclophilin inhibitor CC-1233 in models of acute pancreatitis at the American Pancreatic Association annual meeting in San Diego (Nov. 8-11th, 2017).

  November 9, 2017

   · 

  3 min read
• Drug Development

  Bavarian Nordic Announces Initiation of Phase II Booster Study of its Universal RSV Vaccine

  This study is designed to help determine whether a single shot administration of vaccine is required annually, or if it remains effective over multiple seasons.

  November 9, 2017

   · 

  3 min read
• Business

  NeoGenomics Europe S.A. Opens Its Doors in Rolle, Switzerland Laboratory Hosting Business Leaders, Dignitaries and Local Government Officials

  NeoGenomics opened the doors of its new Rolle, Switzerland facility on Wednesday, November 8th to bring its unique Pharma Services offering to the global research community.

  November 9, 2017

   · 

  2 min read
• Business

  Globus Medical Reports Third Quarter 2017 Results

  Worldwide sales were $151.7 million, an increase of 11.9% as reported, and 11.8% in constant currency.

  November 9, 2017

   · 

  16 min read
• Business

  Pulmatrix Provides Q3 2017 Highlights and Q3 2017 Updated Financials

  Vectura and/or its partners will be responsible for all future development costs to advance the product for the U.S. Pulmatrix will provide the data package for PUR0200 and assist with the transfer of development and manufacturing activities to Vectura.

  November 9, 2017

   · 

  14 min read
• Business

  Eleven Biotherapeutics to Report Third Quarter 2017 Financial Results on November 14, 2017

  Eleven Biotherapeutics announced it will host a live conference call and webcast at 4:30 p.m. ET on Tuesday, November 14, 2017 to report its third quarter 2017 financial results and provide a corporate update.

  November 9, 2017

   · 

  1 min read
• Business

  apceth Biopharma Appoints a New Supervisory Board

  Manfred Ruediger, Chairman, is a seasoned senior executive with over 20 years’ experience in leading biotech companies both at the management and board levels.

  November 9, 2017

   · 

  3 min read